SARC046: A Phase II Trial of Nab-Sirolimus in Patients With Progressing or Symptomatic Epithelioid Hemangioendothelioma
Sarcoma Alliance for Research through Collaboration
Sarcoma Alliance for Research through Collaboration
Institut Claudius Regaud
St. Jude Children's Research Hospital
BridGene Biosciences Inc.